{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:45:55Z","timestamp":1787946355095,"version":"build-2784847793"},"reference-count":145,"publisher":"The Royal Society","issue":"1957","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000271","name":"Science and Technology Facilities Council UK","doi-asserted-by":"crossref","award":["ST\/S000682\/1"],"award-info":[{"award-number":["ST\/S000682\/1"]}],"id":[{"id":"10.13039\/501100000271","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The epidermal growth factor receptor (EGFR) was cloned and identified as an oncogene 40 years ago, and since then has become the poster child for receptor tyrosine kinases in physiological and pathophysiological settings. Cell surface EGFRs bind growth factors secreted by adjacent cells and undergo conformational changes that transduce normal or dysregulated growth and division signals across the plasma membrane. It took more than two decades for atomic resolution of partial structures to become available, including the growth factor-bound ectodomain dimer, the active kinase monomer, the autoinhibited ectodomain monomer, the active asymmetric kinase dimer, the inactive symmetric dimer, transmembrane dimers and the inner juxtamembrane domain. These crystallographic structures paved the way for investigations of the architecture of EGFR assemblies on cells, which in the past decade have revealed the existence of oligomers, whose structure has been examined using high-resolution fluorescence microscopy combined with large-scale molecular dynamics simulations. Understanding the structure of EGFR monomers and dimers has already transformed our mechanistic understanding of cancer treatment, in some cases extending overall survival from months to a handful of years. It is eminently possible that the subsequent exploitation of information on oligomer structure will complement these achievements and overcome some of the current hurdles.<\/jats:p>\n                  <jats:p>This article is part of the discussion meeting issue \u2018Epidermal growth factor receptor after 40 years\u2019.<\/jats:p>","DOI":"10.1098\/rstb.2024.0513","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:09:56Z","timestamp":1787814596000},"source":"Crossref","is-referenced-by-count":1,"title":["Piecing together the structure of epidermal growth factor receptor complexes: a journey from crystals to cells and its impact on cancer therapy"],"prefix":"10.1098","volume":"381","author":[{"given":"Selene","family":"Roberts","sequence":"first","affiliation":[{"name":"Central Laser Facility, Rutherford Appleton Laboratory 1 , Didcot, Oxfordshire OX11 0FA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Clarke","sequence":"additional","affiliation":[{"name":"Central Laser Facility, Rutherford Appleton Laboratory 1 , Didcot, Oxfordshire OX11 0FA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Galdadas","sequence":"additional","affiliation":[{"name":"Atomistic Simulations, Italian Institute of Technology 2 , Genova, 16163, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5496-6300","authenticated-orcid":false,"given":"Marisa","family":"Martin-Fernandez","sequence":"additional","affiliation":[{"name":"Central Laser Facility, Rutherford Appleton Laboratory 1 , Didcot, Oxfordshire OX11 0FA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"175","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026082703095414000_RSTB20240513C1","doi-asserted-by":"crossref","first-page":"R292","DOI":"10.1016\/S0960-9822(01)00167-1","article-title":"Epidermal growth factor receptor signaling","volume":"11","author":"Bogdan","year":"2001","journal-title":"Curr. Biol."},{"key":"2026082703095414000_RSTB20240513C2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/309418a0","article-title":"Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells","volume":"309","author":"Ullrich","year":"1984","journal-title":"Nature"},{"key":"2026082703095414000_RSTB20240513C3","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: signaling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers"},{"key":"2026082703095414000_RSTB20240513C4","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1128\/MCB.00742-10","article-title":"Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor","volume":"30","author":"Lu","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"2026082703095414000_RSTB20240513C5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccr.2005.03.003","article-title":"Structural basis for inhibition of the epidermal growth factor receptor by cetuximab","volume":"7","author":"Li","year":"2005","journal-title":"Cancer Cell"},{"key":"2026082703095414000_RSTB20240513C6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/08977194.2011.649918","article-title":"EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling","volume":"30","author":"Wilson","year":"2012","journal-title":"Growth Factors"},{"key":"2026082703095414000_RSTB20240513C7","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1073\/pnas.96.11.6235","article-title":"Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor","volume":"96","author":"Dong","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703095414000_RSTB20240513C8","first-page":"1831","article-title":"Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling","volume":"8","author":"Lax","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"2026082703095414000_RSTB20240513C9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1021\/bi00379a035","article-title":"Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor","volume":"26","author":"Yarden","year":"1987","journal-title":"Biochemistry"},{"key":"2026082703095414000_RSTB20240513C10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2023.03.003","article-title":"Multiple post-translational modifications ensure EGFR functionality: potential therapeutic targets to overcome its drug-resistance mutations","volume":"70","author":"He","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"2026082703095414000_RSTB20240513C11","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1073\/pnas.1105666108","article-title":"Regulation of human EGF receptor by lipids","volume":"108","author":"Coskun","year":"2011","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703095414000_RSTB20240513C12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/93.18.1375","article-title":"Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells","volume":"93","author":"Alper","year":"2001","journal-title":"J. Natl Cancer. Inst."},{"key":"2026082703095414000_RSTB20240513C13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"key":"2026082703095414000_RSTB20240513C14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0014-4827(02)00097-6","article-title":"The epidermal growth factor system in Caenorhabditis elegans","volume":"284","author":"Moghal","year":"2003","journal-title":"Exp. Cell Res."},{"key":"2026082703095414000_RSTB20240513C15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/cancers9020016","article-title":"Epidermal growth factor pathway signaling in Drosophila embryogenesis: tools for understanding cancer","volume":"9","author":"Lusk","year":"2017","journal-title":"Cancers"},{"key":"2026082703095414000_RSTB20240513C16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/08977190802312844","article-title":"EGFR family: structure physiology signalling and therapeutic targets","volume":"26","author":"Burgess","year":"2008","journal-title":"Growth Factors"},{"key":"2026082703095414000_RSTB20240513C17","doi-asserted-by":"crossref","first-page":"a020768","DOI":"10.1101\/cshperspect.a020768","article-title":"The EGFR family: not so prototypical receptor tyrosine kinases","volume":"6","author":"Lemmon","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2026082703095414000_RSTB20240513C18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/jcp.21635","article-title":"The epidermal growth factor receptor ligands at a glance","volume":"218","author":"Schneider","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"2026082703095414000_RSTB20240513C19","doi-asserted-by":"crossref","first-page":"e220105","DOI":"10.1530\/JME-22-0105","article-title":"The epidermal growth factor receptor in healthy pregnancy and preeclampsia","volume":"70","author":"Clemente","year":"2023","journal-title":"J. Mol. Endocrinol."},{"key":"2026082703095414000_RSTB20240513C20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0070-2153(08)60257-4","article-title":"The EGFR gene family in embryonic cell activities","volume":"35","author":"Adamson","year":"1997","journal-title":"Curr. Top Dev. Biol."},{"key":"2026082703095414000_RSTB20240513C21","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1242\/dev.00664","article-title":"Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart","volume":"130","author":"Sibilia","year":"2003","journal-title":"Development"},{"key":"2026082703095414000_RSTB20240513C22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/cells9081887","article-title":"Role of EGFR in the nervous system","volume":"9","author":"Romano","year":"2020","journal-title":"Cells"},{"key":"2026082703095414000_RSTB20240513C23","doi-asserted-by":"crossref","first-page":"16 257","DOI":"10.1073\/pnas.0508521102","article-title":"Epidermal growth factor receptor signaling is required for normal ovarian steroidogenesis and oocyte maturation","volume":"102","author":"Jamnongjit","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703095414000_RSTB20240513C24","doi-asserted-by":"crossref","first-page":"e202012073","DOI":"10.1083\/jcb.202012073","article-title":"EGFR-mediated epidermal stem cell motility drives skin regeneration through COL17A1 protesolysis","volume":"220","author":"Nanba","year":"2021","journal-title":"J. Cell Biol."},{"key":"2026082703095414000_RSTB20240513C25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.0022-202X.2004.23478.x","article-title":"EGFR enhances early healing after cutaneous incisional wounding","volume":"123","author":"Repertinger","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"2026082703095414000_RSTB20240513C26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jbmr.4531","article-title":"EGFR signaling is required for maintaining adult cartilage homeostasis and attenuating osteoarthritis progression","volume":"37","author":"Wei","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"2026082703095414000_RSTB20240513C27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/307521a0","article-title":"Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences","volume":"307","author":"Downward","year":"1984","journal-title":"Nature"},{"key":"2026082703095414000_RSTB20240513C28","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0092-8674(83)90307-0","article-title":"The product of the avian erythroblastosis virus erbB locus is a glycoprotein","volume":"32","author":"Privalsky","year":"1983","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"2026082703095414000_RSTB20240513C30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0167-4838(87)90112-9","article-title":"On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors","volume":"916","author":"Bajaj","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"2026082703095414000_RSTB20240513C31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/prot.340220207","article-title":"Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor","volume":"22","author":"Ward","year":"1995","journal-title":"Proteins: Struct. Funct. Genet."},{"key":"2026082703095414000_RSTB20240513C32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/j.1460-2075.1989.tb03393.x","article-title":"Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken\/human receptor molecules","volume":"8","author":"Lax","year":"1989","journal-title":"EMBO J."},{"key":"2026082703095414000_RSTB20240513C33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0092-8674(02)00963-7","article-title":"Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains","volume":"110","author":"Ogiso","year":"2002","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(02)00940-6","article-title":"Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha","volume":"110","author":"Garrett","year":"2002","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C35","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1128\/MCB.25.17.7734-7742.2005","article-title":"Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface","volume":"25","author":"Dawson","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"2026082703095414000_RSTB20240513C36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C37","doi-asserted-by":"crossref","first-page":"10 861","DOI":"10.1073\/pnas.1201114109","article-title":"A single ligand is sufficient to activate EGFR dimers","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703095414000_RSTB20240513C38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41421-023-00523-5","article-title":"Structure and dynamics of the EGFR\/HER2 heterodimer","volume":"9","author":"Bai","year":"2023","journal-title":"Cell Discov."},{"key":"2026082703095414000_RSTB20240513C39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41586-021-04084-z","article-title":"Structures of the HER2-HER3-NRG1beta complex reveal a dynamic dimer interface","volume":"600","author":"Diwanji","year":"2021","journal-title":"Nature"},{"key":"2026082703095414000_RSTB20240513C40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/emboj\/16.2.281","article-title":"Two EGF molecules contribute additively to stabilization of the EGFR dimer","volume":"16","author":"Lemmon","year":"1997","journal-title":"EMBO J."},{"key":"2026082703095414000_RSTB20240513C41","doi-asserted-by":"crossref","first-page":"35 985","DOI":"10.1074\/jbc.274.50.35985","article-title":"Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor","volume":"274","author":"Tanner","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(03)00047-9","article-title":"EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization","volume":"11","author":"Ferguson","year":"2003","journal-title":"Mol. Cell"},{"key":"2026082703095414000_RSTB20240513C43","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1074611","article-title":"Structure of the extracellular region of HER3 reveals an interdomain tether","volume":"297","author":"Cho","year":"2002","journal-title":"Science"},{"key":"2026082703095414000_RSTB20240513C44","doi-asserted-by":"crossref","first-page":"15 024","DOI":"10.1073\/pnas.0507591102","article-title":"The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand","volume":"102","author":"Bouyain","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703095414000_RSTB20240513C45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature08297","article-title":"ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor","volume":"461","author":"Alvarado","year":"2009","journal-title":"Nature"},{"key":"2026082703095414000_RSTB20240513C46","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cell.2010.07.015","article-title":"Structural basis for negative cooperativity in growth factor binding to an EGF receptor","volume":"142","author":"Alvarado","year":"2010","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0021-9258(20)71149-X","article-title":"Post-translational processing of the epidermal growth factor receptor. Glycosylation-dependent acquisition of ligand-binding capacity","volume":"260","author":"Slieker","year":"1985","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C48","doi-asserted-by":"crossref","first-page":"12586","DOI":"10.1016\/S0021-9258(18)90787-8","article-title":"Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function","volume":"259","author":"Soderquist","year":"1984","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C49","doi-asserted-by":"crossref","first-page":"21 988","DOI":"10.1074\/jbc.M003400200","article-title":"The Asn-420-linked sugar chain in human epidermal growth factor receptor suppresses ligand-independent spontaneous oligomerization. Possible role of a specific sugar chain in controllable receptor activation","volume":"275","author":"Tsuda","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C50","doi-asserted-by":"crossref","first-page":"8930","DOI":"10.1021\/bi010037b","article-title":"Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain","volume":"40","author":"Elleman","year":"2001","journal-title":"Biochemistry"},{"key":"2026082703095414000_RSTB20240513C51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/08977190009003231","article-title":"Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor","volume":"18","author":"Domagala","year":"2000","journal-title":"Growth Factors"},{"key":"2026082703095414000_RSTB20240513C52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1097-2765(03)00350-2","article-title":"An open-and-shut case? Recent insights into the activation of EGF\/ErbB receptors","volume":"12","author":"Burgess","year":"2003","journal-title":"Mol. Cell"},{"key":"2026082703095414000_RSTB20240513C53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0092-8674(02)00966-2","article-title":"Ligand-induced, receptor-mediated dimerization and activation of EGF receptor","volume":"110","author":"Schlessinger","year":"2002","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(02)00741-9","article-title":"The conformational plasticity of protein kinases","volume":"109","author":"Huse","year":"2002","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cell.2006.05.013","article-title":"An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor","volume":"125","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C56","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cell.2012.12.032","article-title":"Conformational coupling across the plasma membrane in activation of the EGF receptor","volume":"152","author":"Endres","year":"2013","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cell.2012.12.030","article-title":"Architecture and membrane interactions of the EGF receptor","volume":"152","author":"Arkhipov","year":"2013","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C58","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2009.04.025","article-title":"Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment","volume":"137","author":"Jura","year":"2009","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev-biochem-060614-034402","article-title":"A structural perspective on the regulation of the epidermal growth factor receptor","volume":"84","author":"Kovacs","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"2026082703095414000_RSTB20240513C60","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1006\/jmbi.2001.4923","article-title":"Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain","volume":"311","author":"Moriki","year":"2001","journal-title":"J. Mol. Biol."},{"key":"2026082703095414000_RSTB20240513C61","doi-asserted-by":"crossref","first-page":"10 611","DOI":"10.1021\/jacs.6b05602","article-title":"Conformational changes in the epidermal growth factor receptor: role of the transmembrane domain investigated by coarse-grained metadynamics free energy calculations","volume":"138","author":"Lelimousin","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"2026082703095414000_RSTB20240513C62","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/s41467-024-46284-x","article-title":"Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers","volume":"15","author":"Iyer","year":"2024","journal-title":"Nat. Commun."},{"key":"2026082703095414000_RSTB20240513C63","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1042\/BCJ20220472","article-title":"Activity of EGFR transmembrane region variants indicates specific transmembrane dimers are not required for EGFR activity","volume":"479","author":"Bartzoka","year":"2022","journal-title":"Biochem. J."},{"key":"2026082703095414000_RSTB20240513C64","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nsmb.2092","article-title":"Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor","volume":"18","author":"Mi","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026082703095414000_RSTB20240513C65","doi-asserted-by":"crossref","first-page":"13 828","DOI":"10.1016\/S0021-9258(18)92776-6","article-title":"Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain","volume":"266","author":"Lax","year":"1991","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/jmi.13151","article-title":"A perspective of fluorescence microscopy for cellular structural biology with EGFR as witness","volume":"291","author":"Martin-Fernandez","year":"2023","journal-title":"J. Microsc."},{"key":"2026082703095414000_RSTB20240513C67","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2016.10.038","article-title":"EGFR dynamics change during activation in native membranes as revealed by NMR","volume":"167","author":"Kaplan","year":"2016","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C68","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.celrep.2014.10.010","article-title":"Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor","volume":"9","author":"Bessman","year":"2014","journal-title":"Cell Rep."},{"key":"2026082703095414000_RSTB20240513C69","doi-asserted-by":"crossref","first-page":"e1003742","DOI":"10.1371\/journal.pcbi.1003742","article-title":"Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor","volume":"10","author":"Arkhipov","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"2026082703095414000_RSTB20240513C70","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1128\/MCB.01431-10","article-title":"Human epidermal growth factor receptor (EGFR) aligned on the plasma membrane adopts key features of Drosophila EGFR asymmetry","volume":"31","author":"Tynan","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"2026082703095414000_RSTB20240513C71","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbamem.2016.02.023","article-title":"Alternative packing of EGFR transmembrane domain suggests that protein-lipid interactions underlie signal conduction across membrane","volume":"1858","author":"Bocharov","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"2026082703095414000_RSTB20240513C72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/cells6020013","article-title":"Activation of the EGF receptor by ligand binding and oncogenic mutations: the \u201crotation model\u201d","volume":"6","author":"Purba","year":"2017","journal-title":"Cells"},{"key":"2026082703095414000_RSTB20240513C73","doi-asserted-by":"crossref","first-page":"38 244","DOI":"10.1074\/jbc.M112.414391","article-title":"Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor","volume":"287","author":"Lu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C74","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1038\/s41467-018-06632-0","article-title":"The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers","volume":"9","author":"Zanetti-Domingues","year":"2018","journal-title":"Nat. Commun."},{"key":"2026082703095414000_RSTB20240513C75","doi-asserted-by":"crossref","first-page":"011002","DOI":"10.1117\/1.JBO.17.1.011002","article-title":"Energy migration and fluorescence","volume":"17","author":"Forster","year":"2012","journal-title":"J. Biomed. Opt."},{"key":"2026082703095414000_RSTB20240513C76","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.str.2013.05.008","article-title":"Structural evaluation of EGFR inhibition mechanisms for nanobodies\/VHH domains","volume":"21","author":"Schmitz","year":"2013","journal-title":"Structure"},{"key":"2026082703095414000_RSTB20240513C77","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.celrep.2018.02.031","article-title":"Phosphorylated EGFR dimers are not sufficient to activate Ras","volume":"22","author":"Liang","year":"2018","journal-title":"Cell Rep."},{"key":"2026082703095414000_RSTB20240513C78","doi-asserted-by":"crossref","first-page":"30 392","DOI":"10.1074\/jbc.M504770200","article-title":"Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-a multidimensional microscopy analysis","volume":"280","author":"Clayton","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C79","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1529\/biophysj.107.112623","article-title":"Single-molecule imaging and fluorescence lifetime imaging microscopy show different structures for high- and low-affinity epidermal growth factor receptors in A431 cells","volume":"94","author":"Webb","year":"2008","journal-title":"Biophys. J."},{"key":"2026082703095414000_RSTB20240513C80","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4049\/jimmunol.178.2.1021","article-title":"Targeted antireceptor therapy with monoclonal antibodies leads to the formation of inactivated tetrameric forms of ErbB receptors","volume":"178","author":"Furuuchi","year":"2007","journal-title":"J. Immunol."},{"key":"2026082703095414000_RSTB20240513C81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jsb.2009.04.007","article-title":"Ectodomain orientation, conformational plasticity and oligomerization of ErbB1 receptors investigated by molecular dynamics","volume":"167","author":"Kastner","year":"2009","journal-title":"J. Struct. Biol."},{"key":"2026082703095414000_RSTB20240513C82","first-page":"41","article-title":"Anton 2: raising the bar for performance and programmability in a special-purpose molecular dynamics supercomputer","volume-title":"Proc. Int. Conf. High Perform. Comput. Netw. Storage Anal., New Orleans, LA","author":"Shaw","year":"2014"},{"key":"2026082703095414000_RSTB20240513C83","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1038\/ncomms13307","article-title":"EGFR oligomerization organizes kinase-active dimers into competent signalling platforms","volume":"7","author":"Needham","year":"2016","journal-title":"Nat. Commun."},{"key":"2026082703095414000_RSTB20240513C84","doi-asserted-by":"crossref","first-page":"14 742","DOI":"10.3390\/ijms131114742","article-title":"Single molecule fluorescence detection and tracking in mammalian cells: the state-of-the-art and future perspectives","volume":"13","author":"Martin-Fernandez","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"2026082703095414000_RSTB20240513C85","doi-asserted-by":"crossref","first-page":"e14107","DOI":"10.7554\/eLife.14107","article-title":"Molecular basis for multimerization in the activation of the epidermal growth factor receptor","volume":"5","author":"Huang","year":"2016","journal-title":"eLife"},{"key":"2026082703095414000_RSTB20240513C86","doi-asserted-by":"crossref","first-page":"16 524","DOI":"10.1073\/pnas.1002642107","article-title":"Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis","volume":"107","author":"Nagy","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703095414000_RSTB20240513C87","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/cyto.a.22311","article-title":"Dynamic conformational transitions of the EGF receptor in living mammalian cells determined by FRET and fluorescence lifetime imaging microscopy","volume":"83","author":"Ziomkiewicz","year":"2013","journal-title":"Cytometry A"},{"key":"2026082703095414000_RSTB20240513C88","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1529\/biophysj.107.105494","article-title":"Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis","volume":"93","author":"Saffarian","year":"2007","journal-title":"Biophys. J."},{"key":"2026082703095414000_RSTB20240513C89","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0006-3495(02)75585-9","article-title":"Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling","volume":"82","author":"Martin-Fernandez","year":"2002","journal-title":"Biophys. J."},{"key":"2026082703095414000_RSTB20240513C90","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s42003-019-0317-6","article-title":"Solid immersion microscopy images cells under cryogenic conditions with 12 nm resolution","volume":"2","author":"Wang","year":"2019","journal-title":"Commun. Biol."},{"key":"2026082703095414000_RSTB20240513C91","doi-asserted-by":"crossref","first-page":"e62331","DOI":"10.1371\/journal.pone.0062331","article-title":"Measuring EGFR separations on cells with \u223c10 nm resolution via fluorophore localization imaging with photobleaching","volume":"8","author":"Needham","year":"2013","journal-title":"PLoS ONE"},{"key":"2026082703095414000_RSTB20240513C92","doi-asserted-by":"crossref","first-page":"13 353","DOI":"10.1074\/jbc.RA120.012852","article-title":"EGFR forms ligand-independent oligomers that are distinct from the active state","volume":"295","author":"Byrne","year":"2020","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C93","doi-asserted-by":"crossref","first-page":"e2424678122","DOI":"10.1073\/pnas.2424678122","article-title":"Structure and organization of full-length epidermal growth factor receptor in extracellular vesicles by cryo-electron tomography","volume":"122","author":"Gonzalez-Magaldi","year":"2025","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703095414000_RSTB20240513C94","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2012.02.063","article-title":"Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization","volume":"149","author":"Shan","year":"2012","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/onc.2012.21","article-title":"Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor","volume":"32","author":"Yoshikawa","year":"2013","journal-title":"Oncogene"},{"key":"2026082703095414000_RSTB20240513C96","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/MCB.00248-15","article-title":"Analysis of the role of the C-terminal tail in the regulation of the epidermal growth factor receptor","volume":"35","author":"Kovacs","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"2026082703095414000_RSTB20240513C97","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1016\/j.bpj.2022.11.003","article-title":"The dependence of EGFR oligomerization on environment and structure: a camera-based N&B study","volume":"121","author":"Balasubramanian","year":"2022","journal-title":"Biophys. J."},{"key":"2026082703095414000_RSTB20240513C98","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1742-4658.2009.07448.x","article-title":"Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer","volume":"277","author":"Mitsudomi","year":"2010","journal-title":"FEBS J."},{"key":"2026082703095414000_RSTB20240513C99","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2026082703095414000_RSTB20240513C100","first-page":"48","article-title":"Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update","volume":"2","author":"Bethune","year":"2010","journal-title":"J. Thorac. Dis."},{"key":"2026082703095414000_RSTB20240513C101","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5732\/cjc.011.10106","article-title":"East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians","volume":"30","author":"Zhou","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"2026082703095414000_RSTB20240513C102","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cllc.2021.08.012","article-title":"The effects of HER2 alterations in EGFR mutant non-small cell lung cancer","volume":"23","author":"Nagasaka","year":"2022","journal-title":"Clin. Lung Cancer"},{"key":"2026082703095414000_RSTB20240513C103","doi-asserted-by":"crossref","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"2026082703095414000_RSTB20240513C104","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1111\/febs.12393","article-title":"The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered","volume":"280","author":"Gan","year":"2013","journal-title":"FEBS J."},{"key":"2026082703095414000_RSTB20240513C105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C106","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clon.2019.07.014","article-title":"Differences between the East and the West in managing advanced-stage non-small cell lung cancer","volume":"32","author":"Lee","year":"2020","journal-title":"Clin. Oncol."},{"key":"2026082703095414000_RSTB20240513C107","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1479-5876-3-38","article-title":"The natural history of EGFR and EGFRvIII in glioblastoma patients","volume":"3","author":"Heimberger","year":"2005","journal-title":"J. Transl. Med."},{"key":"2026082703095414000_RSTB20240513C108","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5306\/wjco.v6.i5.133","article-title":"Colon cancer and the epidermal growth factor receptor: current treatment paradigms, the importance of diet, and the role of chemoprevention","volume":"6","author":"Pabla","year":"2015","journal-title":"World J. Clin. Oncol."},{"key":"2026082703095414000_RSTB20240513C109","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/cancers3021513","article-title":"Epidermal growth factor receptor in pancreatic cancer","volume":"3","author":"Oliveira-Cunha","year":"2011","journal-title":"Cancers"},{"key":"2026082703095414000_RSTB20240513C110","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3389\/fonc.2020.01249","article-title":"The latest battles between EGFR monoclonal antibodies and resistant tumor cells","volume":"10","author":"Cai","year":"2020","journal-title":"Front. Oncol."},{"key":"2026082703095414000_RSTB20240513C111","doi-asserted-by":"crossref","first-page":"83 207","DOI":"10.18632\/oncotarget.20544","article-title":"Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells","volume":"8","author":"Terzuoli","year":"2017","journal-title":"Oncotarget"},{"key":"2026082703095414000_RSTB20240513C112","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2026082703095414000_RSTB20240513C113","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol."},{"key":"2026082703095414000_RSTB20240513C114","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(15)00021-2","article-title":"Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial","volume":"16","author":"Thatcher","year":"2015","journal-title":"Lancet Oncol."},{"key":"2026082703095414000_RSTB20240513C115","doi-asserted-by":"crossref","DOI":"10.1007\/s11523-025-01128-6","article-title":"The user's guide to Amivantamab","author":"Brazel","year":"2025","journal-title":"Target Oncol."},{"key":"2026082703095414000_RSTB20240513C116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/mmr.2024.13171","article-title":"CAR\u2011T cell therapy: a breakthrough in traditional cancer treatment strategies (Review)","volume":"29","author":"Sun","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"2026082703095414000_RSTB20240513C117","doi-asserted-by":"crossref","first-page":"46 265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2026082703095414000_RSTB20240513C118","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/1078-0432.CCR-03-0564","article-title":"United States food and drug administration drug approval summary: Gefitinib (ZD1839; Iressa) tablets","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"2026082703095414000_RSTB20240513C119","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2026082703095414000_RSTB20240513C120","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"2026082703095414000_RSTB20240513C121","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1158\/1078-0432.CCR-09-0391","article-title":"Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations","volume":"15","author":"Morita","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"2026082703095414000_RSTB20240513C122","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216677","article-title":"Globally approved EGFR inhibitors: insights into their syntheses, target kinases, biological activities, receptor interactions, and metabolism","volume":"26","author":"Abourehab","year":"2021","journal-title":"Molecules"},{"key":"2026082703095414000_RSTB20240513C123","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1158\/0008-5472.CAN-06-2037","article-title":"p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer","volume":"67","author":"Rho","year":"2007","journal-title":"Cancer Res."},{"key":"2026082703095414000_RSTB20240513C124","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)","volume":"366","author":"Thatcher","year":"2005","journal-title":"Lancet"},{"key":"2026082703095414000_RSTB20240513C125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbapap.2009.12.010","article-title":"Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer","volume":"1804","author":"Eck","year":"2010","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"2026082703095414000_RSTB20240513C126","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1038\/s41467-022-34398-z","article-title":"Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations","volume":"13","author":"van Alderwerelt van Rosenburgh","year":"2022","journal-title":"Nat. Commun."},{"key":"2026082703095414000_RSTB20240513C127","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-021-03898-1","article-title":"Structure-based classification predicts drug response in EGFR-mutant NSCLC","volume":"597","author":"Robichaux","year":"2021","journal-title":"Nature"},{"key":"2026082703095414000_RSTB20240513C128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.19.01488","article-title":"Gefitinib alone versus Gefitinib plus chemotherapy for non-small-cell lung cancer with mutated epidermal growth factor receptor: NEJ009 study","volume":"38","author":"Hosomi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"2026082703095414000_RSTB20240513C129","doi-asserted-by":"crossref","first-page":"19 503","DOI":"10.1073\/pnas.0905056106","article-title":"Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition","volume":"106","author":"Faber","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703095414000_RSTB20240513C130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"2026082703095414000_RSTB20240513C131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1200\/JCO.2009.24.7049","article-title":"Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer","volume":"28","author":"Jackman","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"2026082703095414000_RSTB20240513C132","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"2026082703095414000_RSTB20240513C133","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam Sunder","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"2026082703095414000_RSTB20240513C134","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jtho.2018.01.009","article-title":"EGFR T790M and C797S mutations as mechanisms of acquired resistance to Dacomitinib","volume":"13","author":"Kobayashi","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"2026082703095414000_RSTB20240513C135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"121","author":"Leonetti","year":"2019","journal-title":"Br. J. Cancer."},{"key":"2026082703095414000_RSTB20240513C136","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1158\/1078-0432.CCR-22-3901","article-title":"BBT-176, a novel fourth-generation tyrosine kinase inhibitor for osimertinib-resistant EGFR mutations in non-small cell lung cancer","volume":"29","author":"Lim","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"2026082703095414000_RSTB20240513C137","doi-asserted-by":"crossref","first-page":"111055","DOI":"10.1016\/j.intimp.2023.111055","article-title":"Immunotherapy for colorectal cancer: rational strategies and novel therapeutic progress","volume":"126","author":"Rastin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"2026082703095414000_RSTB20240513C138","doi-asserted-by":"crossref","first-page":"20","DOI":"10.36000\/hbT.OH.2020.03.012","article-title":"Critical review of EGFR-mutated NSCLC: what we do and do not know","volume":"3","author":"Meisel","year":"2020","journal-title":"Healthbook TIMES Oncol. Hematol."},{"key":"2026082703095414000_RSTB20240513C139","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-020-00315-3","article-title":"Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials","volume":"5","author":"Lu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"2026082703095414000_RSTB20240513C140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.pharmtox.48.113006.094723","article-title":"Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy","volume":"49","author":"Shangary","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2026082703095414000_RSTB20240513C141","doi-asserted-by":"crossref","first-page":"e000060","DOI":"10.1136\/esmoopen-2016-000060","article-title":"Mechanisms of resistance to EGFR-targeted drugs: lung cancer","volume":"1","author":"Morgillo","year":"2016","journal-title":"ESMO Open"},{"key":"2026082703095414000_RSTB20240513C142","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2026082703095414000_RSTB20240513C143","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41586-025-08586-y","article-title":"Clonal driver neoantigen loss under EGFR TKI and immune selection pressures","volume":"639","author":"Al Bakir","year":"2025","journal-title":"Nature"},{"key":"2026082703095414000_RSTB20240513C144","first-page":"17","article-title":"Protein-protein interaction networks (PPI) and complex diseases","volume":"7","author":"Safari-Alighiarloo","year":"2014","journal-title":"Gastroenterol. Hepatol. Bed Bench."},{"key":"2026082703095414000_RSTB20240513C145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/cts.12957","article-title":"Adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysis","volume":"14","author":"Yin","year":"2021","journal-title":"Clin. Transl. Sci."}],"container-title":["Philosophical Transactions of the Royal Society B: Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article-pdf\/doi\/10.1098\/rstb.2024.0513\/6162334\/rstb.2024.0513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article-pdf\/doi\/10.1098\/rstb.2024.0513\/6162334\/rstb.2024.0513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:10:12Z","timestamp":1787814612000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article\/381\/1957\/20240513\/483102\/Piecing-together-the-structure-of-epidermal-growth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":145,"journal-issue":{"issue":"1957","published-online":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1098\/rstb.2024.0513","relation":{},"ISSN":["0962-8436","1471-2970"],"issn-type":[{"value":"0962-8436","type":"print"},{"value":"1471-2970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"20240513"}}